| Volume 27(2019) > Number 3 | 1. Next generation probiotics in disease amelioration | Chih-Jung Chang, Tzu-Lung Lin, Yu-Ling Tsai, Tsung-Ru Wu, Wei-Fan Lai, Chia-Chen Lu, Hsin-Chih Lai | 615-622 |
| Volume 27(2019) > Number 2 | 1. Analytical methods for cholesterol quantification | Li-Hua Li, Ewelina P. Dutkiewicz, Ying-Chen Huang, Hsin-Bai Zhou, Cheng-Chih Hsu | 375-386 |
| Volume 27(2019) > Number 1 | The current application of nanotechnology in food and agriculture | Xiaojia He, Hua Deng, Huey-min Hwang | 1-21 |
| Volume 27(2019) > Number 3 | 2. Revisit gut microbiota and its impact on human health and disease | Rui-xue Ding, Wei-Rui Goh, Ri-na Wu, Xi-qing Yue, Xue Luo, Wei Wei Thwe Khine, Jun-rui Wu, Yuan-Kun Lee | 623-631 |
| Volume 27(2019) > Number 2 | 2. Development of biomarkers of genitourinary cancer using mass spectrometry-based clinical proteomics | Yi-Ting Chen, Cheng-Han Tsai, Chien-Lun Chen, Jau-Song Yu, Ying-Hsu Chang | 387-403 |
| Volume 27(2019) > Number 1 | Novel technologies in detection, treatment and prevention of substance use disorders | Hichem Moulahoum, Figen Zihnioglu, Suna Timur, Hakan Coskunol | 22-31 |
| Volume 27(2019) > Number 3 | 3. Psychobiotics in mental health, neurodegenerative and neurodevelopmental disorders | Li-Hao Cheng, Yen-Wenn Liu, Chien-Chen Wu, Sabrina Wang, Ying-Chieh Tsai | 632-648 |
| Volume 27(2019) > Number 2 | 3. Current status of MALDI-TOF mass spectrometry in clinical microbiology | Tsung-Yun Hou, Chuan Chiang-Ni, Shih-Hua Teng | 404-414 |
| Volume 27(2019) > Number 1 | Applications of cyclic peptide nanotubes (cPNTs) | Wei-Hsien Hsieh, Jiahorng Liaw | 32-47 |
| Volume 27(2019) > Number 3 | 4. Potential prebiotics and their transmission mechanisms: Recent approaches | Ishu Khangwal, Pratyoosh Shukla | 649-656 |